Abstract
Cadmium (Cd) has been known to cause hyperglycemia with diabetes-related complications in experimental animals; however, the molecular basis underlying this Cd-induced hyperglycemia is not known. Here, we report the novel finding that the impaired glucose tolerance (IGT) in rats induced by CdCl(2) is accompanied by a drastic (by as much as 90%) and dose-dependent reduction in GLUT4 protein and GLUT4 mRNA levels in adipocytes. The effect was specific to GLUT4; neither GLUT1 nor insulin-responsive aminopeptidase in adipocytes was affected. GLUT2 in hepatocytes was also not affected. Interestingly, the effect on GLUT4 was also specific to adipocytes; the muscle tissues of the Cd-treated rats showed only a slight (<25%) reduction in GLUT4 protein level with no change in GLUT4 message level, and again with no change in GLUT1 protein and its message levels. Although the insulin-induced GLUT4 translocation in adipocytes was not affected by the Cd treatment, the 3-O-methy-D-glucose flux in insulin-stimulated adipocytes of Cd-treated rat was drastically reduced. Together these findings clearly demonstrate that Cd induces IGT in rats by selectively down-regulating GLUT4 expression in adipocytes.
Original language | English |
---|---|
Pages (from-to) | 213-20 |
Number of pages | 8 |
Journal | Archives of Biochemistry and Biophysics |
Volume | 413 |
Issue number | 2 |
DOIs | |
State | Published - 15 May 2003 |
Keywords
- 3-O-Methylglucose/metabolism
- Adipocytes/metabolism
- Animals
- Cadmium/pharmacology
- Cadmium Chloride/pharmacology
- Diabetes Mellitus, Experimental
- Dose-Response Relationship, Drug
- Down-Regulation
- Glucose/metabolism
- Glucose Tolerance Test
- Glucose Transporter Type 1
- Glucose Transporter Type 4
- Hyperglycemia
- Male
- Monosaccharide Transport Proteins/metabolism
- Muscle Proteins
- Muscles/metabolism
- RNA, Messenger/metabolism
- Rats
- Rats, Sprague-Dawley
- Reverse Transcriptase Polymerase Chain Reaction
- Time Factors